Physician profile
John C Layke
NPI 1912920109
$9,630.95
in general payments reported to CMS, 2019-2025
14 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,256 · 2020: $35.37 · 2021: $222 · 2022: $210 · 2023: $407 · 2024: $255 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $8,023.46 | 2019 | |
| Abbvie INC. | $534.67 | 2023-2025 | |
| Allergan, INC. | $521.02 | 2019-2022 | |
| Mentor Worldwide LLC | $108.69 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Vertex Pharmaceuticals Incorporated | $97.85 | 2025 | |
| Revance Therapeutics, INC. | $83.26 | 2024 | Daxi, Daxxify |
| Baxter Healthcare | $59.09 | 2025 | Perclot |
| Merz North America, INC. | $58.02 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $35.37 | 2025 | Exparel |
| Integra Lifesciences Corporation | $26.68 | 2025 | Integra, Omnigraft, Surgimend |
| Smith+Nephew, INC. | $21.76 | 2022 | |
| Apollo Endosurgery US INC | $21.69 | 2019 | |
| Motiva USA, LLC | $20.29 | 2024 | |
| Neuronetics, INC. | $19.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Layke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.